11 April 2023 | Features
Revenues considered for the analysis are of Industrial Biotechnogy (Enzymes) products sales for FY 21-22
Mumbai-based Rossari Biotech Ltd recorded 56 per cent growth in 2021-22 with sales revenue of Rs 1073 crore to lead the table of BioSpectrum Top Industrial Biotechnology (Enzymes) Companies 2022 followed by Bengaluru-based Novozymes South Asia Private Limited with sales revenue of Rs 815 crore (second position) and Thane-based Advanced Enzyme Technologies Limited with sales revenue of Rs 536 crore (at third position).
Top 3 companies contribute 69.3% of the total Industrial Biotechnology (Enzymes) market
Top 10 companies contribute 80.7% of the total Industrial Biotechnology (Enzymes) market
BIOSPECTRUM INDUSTRIAL BIOTECHNOLOGY (ENZYMES) SURVEY AND METHODOLOGY
BioSpectrum India, a leading B2B media platform in Lifesciences space since 2003 has re-launched its ranking special edition in June 2019. In this survey we looked at only Industrial Biotechnology (Enzymes) Industry with companies specialising in food & beverage, textile, pharmaceutical, food processing, leather, detergents, paper and pulp and bioenergy. We highlighted the companies (both MNCs and domestic players) based on their achievements in the past financial years.
A detailed questionnaire (survey form) was shared to companies in this space to capture the needed information for the analysis. This was done during December 2022-January 2023. Companies shared information with us to the extent it was possible by them. We have collected information about listed companies from stock exchange and financial agencies and Ministry of Corporate Affairs (MCA) as well.
The revenues considered for the analysis are of Industrial Biotechnogy (Enzymes) products sales. In several cases, where revenue figures were not available, estimates were arrived in discussion with industry experts.
#For all the ranking purposes, we have taken the Industrial Biotechnogy (Enzymes) business only into consideration. Wherever 'Revenue is mentioned, it means, sales turnover from Industrial Biotechnogy (Enzymes) products division. Therefore, revenue wherever mentioned is not necessarily the total sales turnover of the company.
Click here for the survey results of Medical Devices/ Diagnostic Industry for FY 21-22